Vanessa Félix Pires, a PhD student at IGMM within Michael Hahne’s team, supported by the Fondation pour la Recherche Médicale (FRM), shares her work on the enzyme TTLL6, which shows promise for better understanding and detecting colorectal cancer.
Her full interview is available in the FRM April newsletter.
